Literature DB >> 1179456

Chronically impaired autoregulation of cerebral blood flow in long-term diabetics.

N Bentsen, B Larsen, N A Lassen.   

Abstract

Using the arteriovenous oxygen difference method autoregulation of cerebral blood flow (CBF) was tested in 16 long-term diabetics and eight control patients. Blood pressure was raised by angiotensin infusion and lowered by trimethaphan camsylate infusion, in some cases combined with head-up tilting of the patient. Regression analysis was carried out on the results in order to quantify autoregulatory capacity. In the control patients CBF did not vary with moderate blood pressure variations, indicating normal autoregulation. In four of the 16 diabetic patients CBF showed significant pressure dependency, indicating impaired autoregulation. The cause of impaired autoregulation in some long-term diabetics is believed to be diffuse or multifocal dysfunction of cerebral arterioles due to diabetic vascular disease. Other conditions with impaired autoregulation are discussed and compared with that seen in long-term diabetes.

Entities:  

Mesh:

Year:  1975        PMID: 1179456     DOI: 10.1161/01.str.6.5.497

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

Review 1.  Anesthetic considerations in diabetic patients. Part II: intraoperative and postoperative management of patients with diabetes mellitus.

Authors:  Yuji Kadoi
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

2.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

3.  Real-time Noninvasive Monitoring of Intracranial Fluid Shifts During Dialysis Using Volumetric Integral Phase-Shift Spectroscopy (VIPS): A Proof-of-Concept Study.

Authors:  Chethan P Venkatasubba Rao; Eric M Bershad; Eusebia Calvillo; Nelson Maldonado; Rahul Damani; Sreedhar Mandayam; Jose I Suarez
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 4.  Autoregulation in paediatric TBI-current evidence and implications for treatment.

Authors:  Joseph E Donnelly; Adam M H Young; Ken Brady
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

5.  Stroke topography and outcome in relation to hyperglycaemia and diabetes.

Authors:  L Kiers; S M Davis; R Larkins; J Hopper; B Tress; S C Rossiter; J Carlin; S Ratnaike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

6.  Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction.

Authors:  J Kastrup; T Nørgaard; H H Parving; O Henriksen; N A Lassen
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

7.  Neurovascular regulation in the ischemic brain.

Authors:  Katherine Jackman; Costantino Iadecola
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

8.  Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  H H Parving; J Kastrup; U M Smidt
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

9.  Impaired autoregulation of blood flow in skeletal muscle and subcutaneous tissue in long-term Type 1 (insulin-dependent) diabetic patients with microangiopathy.

Authors:  I Faris; H Vagn Nielsen; O Henriksen; H H Parving; N A Lassen
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

10.  Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  H H Parving; H Kastrup; U M Smidt; A R Andersen; B Feldt-Rasmussen; J S Christiansen
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.